ArticleCancer cell2018

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.

Kanika Bajaj Pahuja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.